Anion doping as a probe of cooperativity in the molecular spin-crossover compound [FeL2][BF4]2 (L = 2,6-di{pyrazol-1-yl}pyridine)

The complex dications in the cooperative spin-crossover compound [FeL(2)][BF(4)](2) (2,6-di(pyrazol-1-yl)pyridine) pack through pi-pi interactions into a 2-D layered structure (a "terpyridine embrace" motif). The effects of doping the larger ClO(4)(-) ion into this lattice have been investigated. The bulk solids [FeL(2)][ClO(4)](x)[BF(4)](2-x) are isostructural with [FeL(2)][BF(4)](2) when x = 0.30 and 0.98, and isostructural with (structurally distinct) [FeL(2)][ClO(4)](2) when x = 1.89. When x = 1.68, powder samples are a mixture of both phases, but crystalline material adopts purely the ClO(4)(-) structure. Increasing the perchlorate content in the lattice for 0 < or =x< or = 1.68 causes a small decrease in T(1/2) and a narrowing of hysteresis in their spin-crossover, but with no significant reduction in cooperativity. It also leads to more pronounced decreases in DeltaH [by up to 3.2(5) kJ mol(-1)] and DeltaS [by up to 10(2) J mol(-1) K(-1)] for the transition by DSC. Single crystals of formula [FeL(2)][ClO(4)](y)[BF(4)](2-y) (y = 0.44 and 1.13) are isostructural with the pure BF(4)(-) salt. While their molecular structures are indistinguishable, the distances between cations in the lattice increase in the doped materials. Weakening of intermolecular pi-pi interactions between cations is the likely reason for the reduced enthalpy of spin-crossover as x increases. However, the biggest stuctural change is an increase in the spacing between the 2-D layers with increased ClO(4)(-). These results suggest that cooperativity in this material is transmitted within the terpyridine embrace layers.     

Crystal structure of 1-(4-chlorophenyl)-3-{4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl}-propenone

The title compound C₂₄H₂₂ClNO₂ belongs to the orthorhombic system, space group Pca2₁ with a = 12.1771(10) Å, b = 4.9305(4) Å, c = 34.419(3) Å, α = β = γ = 90°, V = 2066.5(3) ų, Z = 4, D_c = 1.260 g/cm³, F(000) = 824, R = 0.0402 and wR = 0.1144, S = 1.034, T = 293 K. The compound is a chalcone with 4-chlorophenyl and [(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl substituents bonded at the opposite ends of a propenone group, the biologically active region. The propenone bridge makes dihedral angles of 10.61(23)° and 62.75(22)° respectively, with 4-chlorophenyl and the [(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl group.     

Structural Transformations and Spin-Crossover in [FeL2]2+ Salts (L=4-{tert-Butylsulfanyl}-2,6-di{pyrazol-1-yl}pyridine): The Influence of Bulky Ligand Substituents

4-(tert-Butylsulfanyl)-2,6-di(pyrazol-1-yl)pyridine (L) was obtained in low yield from a one-pot reaction of 2,4,6-trifluoropyridine with 2-methylpropane-2-thiolate and sodium pyrazolate in a 1:1:2 ratio. The materials [FeL₂][BF₄]₂⋅solv ( 1[BF₄]₂ ⋅solv) and [FeL₂][ClO₄]₂⋅solv ( 1[ClO₄]₂ ⋅solv; solv=MeNO₂, MeCN or Me₂CO) exhibit a variety of structures and spin-state behaviors including thermal spin-crossover (SCO). Solvent loss on heating 1[BF₄]₂ ⋅x MeNO₂ (x≈2.3) occurs in two steps. The intermediate phase exhibits hysteretic SCO around 250 K, involving a “reverse-SCO” step in its warming cycle at a scan rate of 5 K min⁻¹. The reverse-SCO is not observed in a slower 1 K min⁻¹ measurement, however, confirming its kinetic nature. The final product [FeL₂][BF₄]₂⋅0.75 MeNO₂ was crystallographically characterized, and shows abrupt but incomplete SCO at 172 K which correlates with disorder of an L ligand. The asymmetric unit of 1[BF₄]₂ ⋅y Me₂CO (y≈1.6) contains five unique complex molecules, four of which undergo gradual SCO in at least two discrete steps. Low-spin 1[ClO₄]₂ ⋅0.5 Me₂CO is not isostructural with its BF₄⁻ congener, and undergoes single-crystal-to-single-crystal solvent loss with a tripling of the crystallographic unit cell volume, while retaining the P space group. Three other solvate salts undergo gradual thermal SCO. Two of these are isomorphous at room temperature, but transform to different low-temperature phases when the materials are fully low-spin.     

二{2-{2-{9-乙基-6-[2-(8-羟基喹啉-2-基)乙烯基]咔唑-3-基}乙烯}-8-羟基喹啉}锌配合物的合成与荧光光谱特性

合成了新的N-乙基咔唑衍生物: 3,6-二[2-(8-羟基喹啉基)乙烯基]咔唑(4)及其锌配合物(5); 化合物4经质谱、红外光谱、核磁共振氢谱、元素分析表征其结构, 并测定了它的荧光光谱. 结果显示: 化合物4的荧光发射为蓝绿色光(500 nm), 其发射光谱随着溶剂极性的增大荧光光谱向长波方向移动(即发生红移); 同时, 考察了化合物5的荧光性质, 其荧光发光峰值为600 nm, 与2-甲基-8-羟基喹啉锌相比, 发生了明显的红移.     

Synthesis and tautomerism of 2-[3(5)-aryl(methyl)pyrazol-4-yl]-1-benzimidazoles

An efficient method has been developed for the synthesis of 2-[3(5)-aryl(methyl)pyrazol-4-yl]-1H-benzimidazoles by cyclocondensation of 2-acylmethyl-1H-benzimidazoles benzoylhydrazones with DMF dimethylacetal. The tautomerism of the compounds obtained via migrations of a proton between the pyrazole nitrogen atoms has been studied by ¹H NMR. The more stable tautomers have electron acceptor aryl substituents placed at position 3 of the pyrazole ring and electron donor aryl substituents or a methyl at position 5. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 9, pp. 1370–1377, September, 2006.     

Alternative Synthesis of 5-(1H-Pyrazol-4-yl)-2-{6-[(2,2,6,6-tetramethylpiperidin-4-yl)oxy]pyridazin-3-yl}phenol

A scalable and environmentally benign route to the free base of branaplam, a small molecule splicing modulator, was identified and developed. This alternative approach circumvented the inherent risk of dioxin formation associated with ortho-halo phenol derivatives present in the previous route. A Friedel–Crafts approach provided a reliable access to the key intermediate, subsequently followed by a Suzuki–Miyaura cross-coupling. Multiple process aspects of the synthetic approach were evaluated, and a robust process for its large-scale synthesis was developed and successfully demonstrated.     

Synthesis of 1-[3-methyl-2(3H)-benzazolon-5- or 6-yl]-4-{4-[cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyleneoxyphenyl}piperazines

Reactions of 3-methyl-6-[4-(4-hydroxyphenyl)-1-piperazinyl]-2(3H)-benzoxazolone, 3-methyl-6-[4-(4-hydroxy-phenyl)-1-piperazinyl]-2(3H)-benzothiazolone and 1,3-dimethyl-5-[4-(4-hydroxyphenyl)-1-piperazinyl]-2(3H)-benzimidazolone with cis-{[2-(2,4-dichlorophenyl) -2-(1H-imidazol-1-ylmethyl)]-1,3-dioxolan-4-yl}methyl meth-anesulfonate in the presence of sodium hydride furnish the title compounds.     

Synthesis of (s)-1-{3-[4-(4-benzo[d]isothiazol-3-yl-piperazin-1-yl)-3-fluoro-phenyl]-2-oxo-oxazolidin-5-ylmetyl}-3-substituted-urea derivatives as antibacterial agents

A new series of (s)-1-{3-[4-(4-benzo[d]isothiazol-3-yl-piperazin-1-yl)-3-fluoro-phenyl]-2-oxo-oxazolidin-5-ylmetyl}-3-substituted-urea derivatives have been synthesized and characterized with spectral data, such as IR, NMR and Mass spectroscopies. All compounds are in vitro evaluated for their efficacy as antimicrobial agent against the gram-positive pathogenic strains such as Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228 and Streptococcus pyogens ATCC 8668. Five compounds ( 19k , 19l , 19m , 19n and 19o ) out of 15 compounds showed moderate activity.     

9-苯基芴-4-三苯胺电致发光材料的光电性质

采用HF方法和DFT/B3LYP方法对一种新型的含芴三苯胺,即9-苯基芴-4-三苯胺有机化合物进行了基态结构全优化,CIS方法获得分子最低激发态结构,并采用TD-DFT方法计算分子的吸收光谱和发射光谱.计算结果表明,该分子从基态到激发态的跃迁,几何结构变化主要表现在分子中心三苯胺中苯环和N原子之间的二面角上,吸收及发射光谱的计算结果与实验值一致,吸收光谱为324.52nm,发射光谱为379.01nm,荧光寿命较长,为60.6637ns,是优良的典型蓝色有机电致发光材料.     

Spin crossover in iron(II) complexes with tris(pyrazol-1-yl)methane

Mononuclear iron(II) coordination compounds with tris(pyrazol-1-yl)methane (HC(Pz)₃) described as [Fe{HC(Pz)₃}₂]A₂ × nH₂O, where A = Cl⁻, Br⁻, I⁻, 1/2 SO₄²⁻, n = 0–7, were synthesized. The compounds were studied by static magnetic susceptibility measurements, IR and UV/Vis spectroscopy, and powder X-ray diffraction. The crystal and molecular structures of all compounds were determined by single crystal X-ray diffraction.